ALDH1L1 expression also decreased ZMP sensitivity, indicating the efficacy of ZMP or related AMP analogs in the treatment of HCC with reduced ALDH1L1 expression. The gene discussed is ALDH1L1; the disease is hepatocellular carcinoma.